In 2006, a report from Shinya Yamanaka's lab changed the landscape of stem cell research for good.1 Until that point, generating a source of patient-identical pluripotent stem cells, a major stepping-stone in the quest for stem cell therapies, would only have been possible by cloning a human, generating an embryo and deriving embryonic stem cells, ... (more)
http://circres.ahajournals.org/content/early/2012/12/10/CIRCRESAHA.112.281105.short?rss=1
http://circres.ahajournals.org/content/early/2012/12/10/CIRCRESAHA.112.281105.short?rss=1
No comments:
Post a Comment